Tetsuo Toyama

Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis

Shinji Noda, Yoshihide Asano, Satoshi Nishimura et al. · Nature Communications · 2014 · 144 citations · Full text

Medicine, Immunology, Pathology +11

Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis

Tetsuo Toyama, Agnieszka Looney, Brendon M. Baker et al. · Journal of Investigative Dermatology · 2017 · 98 citations · Full text

Medicine, Molecular Medicine, Pharmacology +14

Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin‐Treated Fli‐1–Haploinsufficient Mice

Takashi Taniguchi, Yoshihide Asano, Kaname Akamata et al. · Arthritis & Rheumatology · 2014 · 86 citations · Full text

Medicine, Genetics, Pathology +17

Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma

Takehiro Takahashi, Yoshihide Asano, Koji Sugawara et al. · The Journal of Experimental Medicine · 2017 · 86 citations · Full text

Medicine, Cell Biology, Pathology +17

CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis

Takashi Taniguchi, Takuya Miyagawa, Satoshi Toyama et al. · Experimental Dermatology · 2018 · 70 citations

Life Sciences, Immunology, Pathology +17